174 related articles for article (PubMed ID: 12065735)
1. Schedule-dependent interaction between vinblastine and cisplatin in Ehrlich ascites tumors in mice.
Cemazar M; Auersperg M; Scancar J; Kirbis IS; Pogacnik A; Sersa G
J Pharmacol Exp Ther; 2002 Jul; 302(1):337-43. PubMed ID: 12065735
[TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
Fujimoto S; Chikazawa H
Jpn J Cancer Res; 1998 Dec; 89(12):1343-51. PubMed ID: 10081496
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
[TBL] [Abstract][Full Text] [Related]
4. Cell death in relation to cell cycle in a mouse ascites tumor growing in vivo after combined treatment with cisplatin and 5-fluorouracil.
Lewin F; Skog S; Tribukait B; Ringborg U
Anticancer Drugs; 1990 Oct; 1(1):37-44. PubMed ID: 2131035
[TBL] [Abstract][Full Text] [Related]
5. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
Fujimoto S
Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
[TBL] [Abstract][Full Text] [Related]
7. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
8. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
Wang GW; Guo W; Tang XD; Peng CL; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
[TBL] [Abstract][Full Text] [Related]
9. Experimental chemotherapy against canine mammary cancer xenograft in SCID mice and its prediction of clinical effect.
Yamashita A; Maruo K; Suzuki K; Shirota K; Kobayashi K; Hioki K
J Vet Med Sci; 2001 Aug; 63(8):831-6. PubMed ID: 11558535
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
[TBL] [Abstract][Full Text] [Related]
11. Microfluorometric investigations on the cell cycle progression of experimental ascites tumors treated with alkaloidic drugs.
Stöhr M; Fischinger W
Arzneimittelforschung; 1978; 28(6):977-81. PubMed ID: 582007
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent interaction between vinblastine and irradiation in experimental sarcoma.
Cemazar M; Dolinsek T; Kosjek T; Markelc B; Sersa G; Kloboves V; Strojan P
Strahlenther Onkol; 2014 Jul; 190(7):661-6. PubMed ID: 24615190
[TBL] [Abstract][Full Text] [Related]
13. Combination of etanidazole with cyclophosphamide and platinum complexes.
Teicher BA; Herman TS; Shulman L; Bubley G; Coleman CN; Frei E
Cancer Chemother Pharmacol; 1991; 28(3):153-8. PubMed ID: 1830248
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
Suzumura Y; Kato T; Ueda R; Ota K
Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with cis-platinum, vinblastine and adriamycin for non-small cell lung cancer].
Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Imajou K; Ozeki H; Nagamine D; Shinagawa K
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3295-300. PubMed ID: 2825603
[TBL] [Abstract][Full Text] [Related]
16. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
El-Naa MM; Othman M; Younes S
Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content.
Cemazar M; Milacic R; Miklavcic D; Dolzan V; Sersa G
Anticancer Drugs; 1998 Jul; 9(6):525-30. PubMed ID: 9877240
[TBL] [Abstract][Full Text] [Related]
19. Lentinan enhances sensitivity of mouse colon 26 tumor to cis-diamminedichloroplatinum (II) and decreases glutathione transferase expression.
Murata T; Hatayama I; Kakizaki I; Satoh K; Sato K; Tsuchida S
Jpn J Cancer Res; 1996 Nov; 87(11):1171-8. PubMed ID: 9045947
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]